SC seeks Centre’s reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19

By: |
October 29, 2020 2:16 PM

A bench headed by Chief Justice S A Bobde issued notice to the Centre on the plea and sought its response in four weeks.

The reasons for the lower SARS-CoV-2 antibody levels in the BCG group were not clear, according to Moshe Arditi, co-senior author of the study. (Representational image)

The Supreme Court Thursday sought response from the Centre on a plea alleging that two medicines Remdesivir and Favipiravir, are being used for treatment of COVID-19 without approval. A bench headed by Chief Justice S A Bobde issued notice to the Centre on the plea and sought its response in four weeks.

Advocate M L Sharma petitioner in-person referred to the bench, also comprising Justices A S Bopanna and V Ramasubramanian, the World Health Organization (WHO) report of October 15 and said that nowhere these medicines are designated officially as medicines for coronavirus.

The bench said that it is only going to make central government aware of it and therefore issuing notice. On September 16, the top court had said that there was an approval by the central government on use of Remdesivir and Favipiravir, as medicines to treat COVID-19.

The top court was hearing a plea seeking registration of an FIR by the CBI against ten Indian pharmaceutical firms for manufacturing and selling these two medicines for treating COVID-19 patients allegedly without valid licences.

Remdesivir and Favipiravir are antiviral drugs and their efficacy in treating COVID-19 patients has been a matter of debate among medical experts.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1COVID-19: On average 1,000 virus particles transmitted during an infection, study says
2Coronavirus in Delhi: As Covid-19 cases plummet, vacant beds show an increase by 30 per cent
3Transporting Coronavirus Vaccine: ‘Mission of the Century’ for airlines to ship Covid vaccines